Detalhe da pesquisa
1.
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
Blood
; 126(1): 42-9, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918346
2.
Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia.
Blood
; 123(17): 2663-72, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24553174
3.
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.
Blood
; 124(5): 750-60, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850760
4.
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.
Blood
; 124(1): 49-62, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797299
5.
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
Lancet Oncol
; 12(3): 236-44, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354370
6.
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
J Clin Oncol
; 39(18): 1983-1994, 2021 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822650
7.
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Leukemia
; 34(4): 1038-1051, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32042081
8.
Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
J Clin Oncol
; 29(26): 3559-66, 2011 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21844497